Centene Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Centene Corporation
- Ownership
- Public
- Status
- Active
- SIC code
- 6324 — Hospital & Medical Service Plans
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- ST Louis
- Headquarters state / province
- Missouri
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CNC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001071739
- EIN
- 04-1406317
Board of directors
-
Christopher J. Coughlin · DirectorSince 2022
-
Frederick H. Eppinger · DirectorSince 2023
-
H. James Dallas · DirectorSince 2023
-
Jessica L. Blume · DirectorSince 2023
-
Kenneth A. Burdick · DirectorSince 2022
-
Kenneth Tanji · DirectorSince 2025
-
Lauren M. Tyler · DirectorSince 2026
-
Lori Jean Robinson · DirectorSince 2023
-
Monte E. Ford · DirectorSince 2023
-
Paul J. Diaz · DirectorSince 2026
-
Richard A. Gephardt · DirectorSince 2023
-
Sarah London · Director · Chief Executive OfficerSince 2023
-
Theodore R. Samuels II · DirectorSince 2023
-
Thomas Greco · DirectorSince 2024
-
Wayne S. DeVeydt · DirectorSince 2023
-
William L. Trubeck · DirectorSince 2023
Chief executives
Sarah London
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
86.1%
-
92.3%
-
93.8%
-
94.2%
-
95.7%
-
97.7%
-
99.0%
-
99.1%
-
99.2%
Board connections
11 of this board's directors also sit on 17 other boards.
- via Monte E. Ford and Theodore R. Samuels II
- via Thomas Greco
- via Monte E. Ford
- via Theodore R. Samuels II
- via Lauren M. Tyler
- via Paul J. Diaz
- via Monte E. Ford
- via H. James Dallas
- via Lori Jean Robinson
- via Kenneth A. Burdick
- via Paul J. Diaz
- via Lori Jean Robinson
- via Kenneth Tanji
- via Frederick H. Eppinger
- via Wayne S. DeVeydt
- via Thomas Greco
- via Thomas Greco
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $14,630,784
- 5 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | PIENKOS THEODORE J Officer (Corporate Controller & CAO) | Shares withheld for tax | −1,092 | $69.41 | $75,796 |
| Aug 26, 2026 | KOSTER CHRISTOPHER Officer (Secretary & General Counsel) | Open-market sale | −56,500 | $66.90 | $3,779,850 |
| Aug 18, 2026 | KOSTER CHRISTOPHER Officer (Secretary & General Counsel) | Open-market sale | −47,603 | $65.36 | $3,111,332 |
| Jul 28, 2026 | Paul J. Diaz Director | Grant or award | +2,771 | — | — |
| Jul 17, 2026 | Lauren M. Tyler Director | Grant or award | +3,155 | — | — |
| Jun 30, 2026 | Christopher J. Coughlin Director | Grant or award | +562 | — | — |
| Jun 30, 2026 | Frederick H. Eppinger Director | Grant or award | +833 | — | — |
| Jun 30, 2026 | Theodore R. Samuels II Director | Grant or award | +465 | — | — |
| Jun 30, 2026 | Kenneth Tanji Director | Grant or award | +581 | — | — |
| Jun 30, 2026 | Lauren M. Tyler Director | Grant or award | +61 | — | — |
| Jun 15, 2026 | SMITH SUSAN RAYE Officer (Chief Operating Officer) | Shares withheld for tax | −483 | $65.19 | $31,487 |
| Jun 10, 2026 | Kenneth A. Burdick Director | Open-market sale | −80,000 | $64.55 | $5,164,000 |
| May 12, 2026 | Kenneth Tanji Director | Grant or award | +3,992 | — | — |
| May 12, 2026 | Theodore R. Samuels II Director | Grant or award | +3,992 | — | — |
| May 12, 2026 | Monte E. Ford Director | Grant or award | +3,992 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.